A Comparison of Tumescence in Breast Reduction Surgery

Completed · Phase 4

Conditions studied: Pain, Postoperative, Postoperative Nausea and Vomiting

In brief

The investigators' main hypothesis is that in breast reduction surgery, the use of tumescent solution containing both dilute lidocaine and epinephrine will lead to better control of postoperative pain, nausea, vomiting, shorter time through postoperative phases of care, quicker discharge from the hospital and lower numbers of hospital readmissions than the use of tumescent solution containing only dilute epinephrine.

Key facts

Study ID

NCT01602692

Run by

University of Wisconsin, Madison

People needed

40

Starts

2012-08-01

Expected to finish

2014-07-01

Last updated by the study team

2020-10-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• all patients presenting for breast reduction surgery at the University of Wisconsin Hospital and Clinics and the University of Wisconsin Transformations Surgery Center and who do not meet any of the exclusion criteria.

You may not qualify if…

• Women under the age of 18 years
• Breast feeding or pregnant women
• Incarcerated women.
• Women unable to give consent because of impaired decision making ability.
• Women who have reported allergies to the substances that will be used in the study.

Where it is running

• University of Wisconsin Transformations Surgery Center — Middleton, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.